Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases
…, SC Antolin, CM Morales, JG Herrero, ED Alvarez… - RMD open, 2022 - rmdopen.bmj.com
Background Patients with immune-mediated rheumatic diseases (IMRDs) are commonly
treated with immunosuppressors and prone to infections. Recently introduced mRNA SARS-…
treated with immunosuppressors and prone to infections. Recently introduced mRNA SARS-…
Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
CS Santos, XC Férnandez, CM Morales, ED Álvarez… - RMD open, 2021 - rmdopen.bmj.com
Background The recent outbreak of COVID-19 has raised concerns in the rheumatology
community about the management of immunosuppressed patients diagnosed with inflammatory …
community about the management of immunosuppressed patients diagnosed with inflammatory …
Risk factors for cardiovascular disease in primary Sjögren's syndrome (pSS): A 20-year follow-up study
…, CM Morales, CÁ Castro, ED Álvarez - Clinical …, 2023 - Springer
Introduction Primary Sjögren’s syndrome (pSS) is a systemic autoimmune disease characterized
by a chronic grade of inflammation. Cardiovascular events represent the major causes …
by a chronic grade of inflammation. Cardiovascular events represent the major causes …
Evaluación de resultados a largo plazo en acogimiento residencial de protección a la infancia
J Fernández, E Álvarez, A Bravo - Infancia y Aprendizaje, 2003 - Taylor & Francis
El acogimiento residencial continúa representando un papel clave en el ámbito de protección
a la infancia. Sin embargo, apenas existen estudios que evalúen el impacto de esta …
a la infancia. Sin embargo, apenas existen estudios que evalúen el impacto de esta …
[HTML][HTML] Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in …
…, JC Alén, AM García-Aparicio, ED Álvarez… - Reumatología …, 2023 - Elsevier
Introduction and objectives This OBSErve Spain study, a part of the international OBSErve
programme, evaluated belimumab real-world use and effectiveness following 6 months of …
programme, evaluated belimumab real-world use and effectiveness following 6 months of …
KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial …
…, MR Guerrero, LS Herránz, ED Álvarez - Seminars in Arthritis and …, 2024 - Elsevier
Background Interstitial lung disease (ILD) is one of the leading causes of mortality in patients
with systemic sclerosis (SSc). Serum biomarkers have been suggested as indicators for …
with systemic sclerosis (SSc). Serum biomarkers have been suggested as indicators for …
Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe?
CS Santos, XC Fernandez, CM Morales, EA Diez… - 2020 - pesquisa.bvsalud.org
BackgroundThe recent outbreak of COVID-19 has raised concerns in the rheumatology
community about the management of immunosuppressive patients diagnosed with inflammatory …
community about the management of immunosuppressive patients diagnosed with inflammatory …
Cardiovascular disease in patients with systemic autoimmune diseases: The relationship between self-perceived risk and actual risk
…, MJ Santos, H Corominas, CÁ Castro, ED Álvarez - Reumatología …, 2024 - Elsevier
Introduction Autoimmune diseases are known to be associated with an elevated risk of
cardiovascular diseases; however, there exists a lack of awareness regarding this increased risk …
cardiovascular diseases; however, there exists a lack of awareness regarding this increased risk …
Clinical phenotype in scleroderma patients based on autoantibodies
…, CM Morales, CA Castro, ED Álvarez - … Advances in Practice, 2023 - academic.oup.com
Objective We aimed to characterize the clinical phenotype of patients with SSc based on
autoantibodies (topoisomerase antibody (Scl-70), ACA and ANA). Methods We included …
autoantibodies (topoisomerase antibody (Scl-70), ACA and ANA). Methods We included …
Refractory Behçet's Disease with Multi-organ Involvement-Learning from Failure
CS Santos, CM Morales, ED Álvarez… - Current …, 2021 - ingentaconnect.com
Background: Beh’s disease (BD) is a rare systemic vasculitis of unknown etiology with
relapsing and remitting course, characterized by triple-symptom complex of recurrent attacks of …
relapsing and remitting course, characterized by triple-symptom complex of recurrent attacks of …